Chronic Kidney Disease Management: Integrating Pharmacotherapy, Biomarkers, and Lifestyle Interventions for Improved Outcomes
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 557
Special Issue Editor
Interests: nephrology; transplantation; clinical epidemiology; meta-analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic kidney disease (CKD) is an escalating global health challenge and one of the leading non-communicable causes of death. Despite advances in research and clinical care, effective CKD management remains hindered by delayed diagnosis, insufficient early nephrology referrals, and limited access to proven treatments. Consequently, patients with CKD continue to face substantial risks of cardiovascular complications and disease progression.
To address these pressing challenges, there is an urgent need for robust, multidisciplinary evidence that enables a holistic approach to CKD management. Such an approach could improve patient quality of life, reduce mortality rates, and mitigate kidney failure progression.
This Special Issue invites original research articles and meta-research studies (including meta-analyses, network meta-analyses, umbrella reviews, and meta-epidemiological studies) that explore innovative strategies for CKD management. We welcome submissions focusing on, but not limited to, the following topics:
- Novel biomarkers for risk stratification in kidney disease progression and cardiovascular complications.
- Dietary interventions and their impact on long-term CKD outcomes.
- Physical activity recommendations and the comparative efficacy of different exercise regimens in CKD patients.
- Efficacy and safety of emerging pharmacological therapies, such as SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists.
- Management of metabolic risk factors and complications, including obesity, diabetes mellitus, and dyslipidemia.
- Addressing disparities in CKD care, including strategies to promote equitable access to novel treatments, dialysis modalities, and kidney transplantation.
We aim to advance the understanding and management of CKD by fostering dialogue across pharmacotherapy, biomarker research, and lifestyle interventions. Submissions that bridge these domains and propose integrative, patient-centered strategies are particularly encouraged.
We look forward to receiving your contributions to this important discussion and to shaping the future of CKD management together.
Dr. Ioannis Bellos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nephrology
- chronic kidney disease
- cardiovascular risk
- risk stratification
- biomarkers
- evidence-based treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
